• CONTACT
  • MARKETCAP
  • BLOG
Coin Mela Coin Mela
  • Home
  • News
    • All News
    • Bitcoin
    • Ethereum
    • XRP
    • Altcoins
    • NFT
    • Blockchain
    • Web3
    • DeFi
    • Finance
    • Stocks
    • Company
  • Learn
  • Market
  • Advertise
Reading: FDA Issues Eye Drop Safety Alert After 3.1 Million Bottles Recalled for Sterility Concerns
Share
  • bitcoinBitcoin(BTC)$66,871.00
  • ethereumEthereum(ETH)$2,055.06
  • tetherTether(USDT)$1.00
  • rippleXRP(XRP)$1.32
  • binancecoinBNB(BNB)$587.85
  • usd-coinUSDC(USDC)$1.00
  • solanaSolana(SOL)$80.31
  • tronTRON(TRX)$0.315109
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.03
  • dogecoinDogecoin(DOGE)$0.091891
CoinMelaCoinMela
Font ResizerAa
  • Home
  • News
  • Learn
  • Market
  • Advertise
Search
  • Home
  • News
    • All News
    • Bitcoin
    • Ethereum
    • XRP
    • Altcoins
    • NFT
    • Blockchain
    • Web3
    • DeFi
    • Finance
    • Stocks
    • Company
  • Learn
  • Market
  • Advertise
Have an existing account? Sign In
Follow US
© Coin Mela Network. All Rights Reserved.
Finance

FDA Issues Eye Drop Safety Alert After 3.1 Million Bottles Recalled for Sterility Concerns

News Desk
Last updated: April 3, 2026 8:53 pm
News Desk
Published: April 3, 2026
Share
thumb eyedrop recall 5671

U.S. health regulators have issued a cautionary warning for consumers to thoroughly check their eye drops, following the voluntary recall of approximately 3.1 million bottles sold across pharmacies nationwide. This action arises from concerns that these products, manufactured by K.C. Pharmaceuticals, may not meet sterility standards. The recall encompasses a range of items, including Artificial Tears, Advanced Relief, Dry Eye Relief, and Redness Lubricant drops.

While the recall does not confirm any actual contamination, it indicates that the manufacturer is unable to assure consumers that the eye drops are free from harmful bacteria or fungi. As part of this precautionary measure, the Food and Drug Administration (FDA) has urged consumers to inspect their medicine cabinets for any potentially unsafe products and dispose of them properly.

The recall includes eight different eye drop products produced by K.C. Pharmaceuticals, sold under various generic store brand names, including Kroger, H-E-B, CVS, Rite Aid, and Walgreens. Among the affected items are Advanced Relief Eye Drops, Ultra Lubricating Eye Drops, and Sterile Eye Drops in both original and redness lubricant formulations. The expiration dates on these products range from April 30 to July 31, 2026, and they can be identified using their Universal Product Code or National Drug Code numbers.

Consumers who have purchased any of the recalled eye drops are advised to discard the products. Although the recall notice did not explicitly outline return procedures, the FDA suggests that items may be returned to the point of purchase for a refund. K.C. Pharmaceuticals initiated the recall on March 31, and it is likely that affected products have already been removed from store shelves. Nonetheless, shoppers are encouraged to verify labels against the recall list if they plan to buy eye drops.

Fortunately, no contamination has been reported, nor has there been any evidence of infections resulting from the use of these specific eye drops. The recall is primarily due to a lack of assurance that the products were manufactured in sterile conditions. If any contamination occurred, there could be a risk of harmful bacteria, fungi, spores, or viruses being present, potentially leading to serious health problems.

Dr. Nicole Bajic, an ophthalmologist at the Cleveland Clinic, highlighted the critical importance of using sterile eye drops to avoid sight-threatening infections. Infections can cause a range of symptoms, including significant pain, yellow or green discharge, and blurred vision. Alarmingly, in 2023, 81 patients developed antibiotic-resistant infections from contaminated eye drops, resulting in four fatalities and several cases requiring surgical intervention.

Bajic notes that distinguishing between common eye irritation and a potential infection can be challenging for patients. She advises anyone experiencing worsening symptoms, such as persistent eye pain or light sensitivity that does not improve with over-the-counter remedies, to seek medical attention promptly.

The FDA enforces a stringent manufacturing process to ensure the safety of sterile eye products. This includes maintaining controlled environments, thorough microbial testing, and an observation period for harmful growths. If any issues are detected, manufacturers must recall the products, with FDA oversight to enforce compliance.

Recalls related to sterility are more prevalent in over-the-counter eye drops compared to prescription products, but remain uncommon due to rigorous regulatory measures. When they do occur, health officials stress the importance of consumer vigilance.

To use eye drops safely, consumers are advised to select true artificial tears rather than redness-reducing products, which can exacerbate issues over time. The rise in recalls, particularly among generic brands, has led some health professionals to recommend brand-name products for increased reliability. Consumers are also cautioned against “natural” or “homeopathic” eye drops that lack FDA regulation, as these may carry risks due to unverified ingredients.

Investing in Gold Bars and Coins: What You Need to Know This Fall
Starbucks to Close Hundreds of U.S. Stores as Part of Restructuring Plan
Ford Shifts Focus to Affordable EVs After Massive Losses on F-150 Lightning
ANZ Faces Record Penalty Over Grubby Conduct in Bond Sale Dealings
Prada Group Acquires Versace in €1.25 Billion Deal
Share This Article
Facebook Whatsapp Whatsapp
ByNews Desk
Follow:
CoinMela News Desk brings you the latest updates, insights, and in-depth coverage from the world of cryptocurrencies, blockchain, and digital finance.
Previous Article L403549868 g Chainlink Struggles Below Key EMAs at $8.94 Amid Geopolitical Fear
Next Article urlhttps3A2F2Fcalifornia times brightspot.s3.amazonaws.com2Fd52Fa12Fc9869ac841c8a753184ce850 U.S. Futures Dip Amid Strong Job Growth and Continued Iran Conflict Concerns
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular News
3dedf59105ad7ed8f02806b239891896
Wall Street Is Predicting a Crash. Wall Street Is Usually Wrong.
1775253833 og
Polymarket Traders Bet on Bitcoin’s Short-Term Price Movement with $104K in Transactions
bitget
Bitget Launches Dynamic VIP Rewards System to Enhance User Engagement
- Advertisement -
Ad image

Follow Us on Socials

We use social media to react to breaking news, update supporters and share information

Twitter Youtube Telegram Linkedin
Coin Mela Coin Mela
CoinMela is your one-stop destination for everything Crypto, Web3, and DeFi news.
  • About Us
  • Contact Us
  • Corrections
  • Terms and Conditions
  • Disclaimer
  • Privacy Policy
  • Advertise with Us
  • Quick Links
  • Company
  • Finance
  • Stocks
  • News
  • Bitcoin
  • XRP
  • Ethereum
  • Altcoins
  • Blockchain
  • DeFi
© Coin Mela Network. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?